Don't miss the most diverse array of global case studies for the marketing of biosimilars!

Your business depends on your ability to construct a firm pathway to market-access for follow-on biopharmaceuticals - and every hour counts. With that in mind we are pleased to invite you to attend the 13th annual Business of Biosimilars and Generic Drugs – the only conference in the United States devoted entirely to giving you the tools you need for successful commercialization of biosimilars!

Our expert faculty will provide you with senior executive-level expert insight on all of your critical success factors, including regulatory approval, IP challenges, and planning and coordinating an international product rollout strategy attuned to the needs of each market.

Featured Speakers include:

• - G. Steven Burrill, CEO, Burrill & Company presenting “Think Different - Navigating the Brave New Globalized Life Science Industry”
• - Alex Kudrin, Medical Director, Takeda Pharmaceuticals presenting “Access the Emerging BRIC Markets for Biosimilars”
• - Bassil Dahiyat, CEO, Xencor presenting “Learn How to Design Profitable Strategic Partnerships for Follow-On Biopharmaceutical Development”

For more information on these case studies and the rest of the event, download the brochure here. 

The 13th Annual Business of Biosimilars and Generic Drugs will take place September 10-12, 2012 in Boston, MA. As a member of the Business of Biosimilars LinkedIn Group, you receive an exclusive discount of 25% off of the standard price when you register to join us. Simply use priority code XP1786LINK. Have any questions about the event? Feel free to contact Jennifer Pereira.

Share this article with your social network, just click below to share now!

Share |

Business of Biosimilars & Generic Drugs Session Spotlight: Think Different—Navigating the Brave New Globalized Life Science Industry

Steve Burrill is one of the most influential and trusted experts and advocates in the biotech industry, bringing over 40 years of experience with him. He has helped establish and grow many companies and stewarded the development of major strategic partnerships. This year at Business of Biosimilars & Generic Drugs, talk he will be discussing the new paradigm of organizational partnerships required for biosimilar development, approval, and commercialization, as well as how the industry must respond to regulatory change in order to grow.

For more information on Steve's presentation and the rest of  the 13th Annual Business of Biosimilars & Generic Drugs taking place September 12-14, 2012 in Boston, MA, download the agenda here.  As a reader of this blog, when you register to join us and mention code XP1786BLOG, you'll receive a discount of 25% off the standard rate.

Featured Session: Think Different—Navigating the Brave New Globalized Life Science Industry
Featured Speaker: G. Steven Burrill, CEO, BURRILL & COMPANY
About the session: G. Steven Burrill is one of the biotech industry’s greatest icons and advocates, with over 40 years of experience in guiding biotech firms towards greater growth, adaptability, and success. Now in the face of dramatic new regulatory changes and a shaky global economy, Mr. Burrill will help you focus on the key factors now impacting follow-on biologics and guide your company towards long-term staying power.

• • Strategic partnerships and acquisitions for biosimilar development: how big is this trend, and how can you take advantage if you aren’t already?
• • Healthcare reform in an election year: make sure that whoever loses in November, you win
• • Outlook and options for reimbursement amid economic uncertainty and global competition

Share this article with your social network, just click below to share now!

Share |

DDP Complimentary Web Seminar: Drug Delivery: A Look Forward

Drug Delivery Partnerships 2012 keynote speaker G. Steven Burrill, CEO, Burrill Company will be joining us on December 20 at 1:30PM to kick-start your DDP Experience. join us for his complimentary web seminar, then join us in Las Vegas for his keynote presentation, "The Globalization of the Pharmaceutical and Biotechnology Industry: What Does it Mean for Your Bottom Line?"

About the web seminar:
The changing world of healthcare, not just driven by Washington and the healthcare reform dialogue, but by a confluence of technology changing everything from the way drugs/devices/diagnostics are discovered and developed to how they are delivered and paid for has revolutionized the industry. Never in the history of medicine have we seen such dramatic change! This seminar will discuss what these changes mean to the pharma and biotech industries.

What you will learn:
· What is happening now that’s causing dramatic change in the industry
· What is currently changing in the industry
· How the industry is adapting to this change
· What the future looks like

Presented by:  G. Steven Burrill, CEO, BURRILL & COMPANY
When: Tuesdsay, December 20, 2011, 1:30PM

Click here to register today! Mention Priority Code XP1778W1BLOG

Share this article with your social network, just click below to share now!

Share |